Cancer stem cell survival relies on the activation of inflammatory pathways, which is speculatively triggered by cell autonomous mechanisms or by microenvironmental stimuli. Here, we observed that hypoxic bone marrow stroma-derived transforming growth factor-β 1 promotes the growth of human breast cancer stem cells as mammospheres. The ensuing Slug-dependent serine 139 phosphorylation of the DNA damage sensor H2AX in breast cancer stem cells induces tumor necrosis factor-α and IL-8 mRNAs, whose stability is enhanced by cytoplasmic β-catenin. β-Catenin also up-regulates and binds miR-221, reducing the stability of the miR-221 targets Rad51 and ERα mRNAs. Our data show that the Slug/β-catenin-dependent activation of DNA damage signaling triggered by the hypoxic microenvironment sustains the proinflammatory phenotype of breast cancer stem cells.

Slug/β-Catenin–Dependent Proinflammatory Phenotype in Hypoxic Breast Cancer Stem Cells

STORCI, GIANLUCA;BERTONI, SARA;DE CAROLIS, SABRINA;PAPI, ALESSIO;CECCARELLI, CLAUDIO;PIRAZZINI, CHIARA;GARAGNANI, PAOLO;FIORENTINO, MICHELANGELO;CAPIZZI, ELISA;GRUPPIONI, ELISA;TAFFURELLI, MARIO;FRANCESCHI, CLAUDIO;BANDINI, GIUSEPPE;BONIFAZI, FRANCESCA;BONAFE', MASSIMILIANO
2013

Abstract

Cancer stem cell survival relies on the activation of inflammatory pathways, which is speculatively triggered by cell autonomous mechanisms or by microenvironmental stimuli. Here, we observed that hypoxic bone marrow stroma-derived transforming growth factor-β 1 promotes the growth of human breast cancer stem cells as mammospheres. The ensuing Slug-dependent serine 139 phosphorylation of the DNA damage sensor H2AX in breast cancer stem cells induces tumor necrosis factor-α and IL-8 mRNAs, whose stability is enhanced by cytoplasmic β-catenin. β-Catenin also up-regulates and binds miR-221, reducing the stability of the miR-221 targets Rad51 and ERα mRNAs. Our data show that the Slug/β-catenin-dependent activation of DNA damage signaling triggered by the hypoxic microenvironment sustains the proinflammatory phenotype of breast cancer stem cells.
2013
Gianluca Storci;Sara Bertoni;Sabrina De Carolis;Alessio Papi;Marina Nati;Claudio Ceccarelli;Chiara Pirazzini;Paolo Garagnani;Alberto Ferrarini;Genny Buson;Massimo Delledonne;Michelangelo Fiorentino;Elisa Capizzi;Elisa Gruppioni;Mario Taffurelli;Donatella Santini;Claudio Franceschi;Giuseppe Bandini;Francesca Bonifazi;Massimiliano Bonafé
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/250533
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 8
  • Scopus 18
  • ???jsp.display-item.citation.isi??? 13
social impact